0.50 Prescribed

Case Study on Acute Migraine Treatment: Beyond Triptans

by Haymarket Medical Education

Credit available Tue 06/30/20 - Wed 06/30/21

Self-Study

for up to 0.50 Prescribed credits

Activity Icon
Self-Study

Better understanding of the pathophysiology of migraine as a neurovascular disorder has resulted in new targets for drug development. Three experts on migraine treatment describe new and emerging medications for acute migraine treatment that target specific pain messengers: 5-HT 1F receptor agonists and calcitonin gene-regulated protein (CGRP) receptor antagonists.

Learn more

Contact Info

List of Sessions

Session Name Date Credits
Case Study on Acute Migraine Treatment: Beyond Triptans Credit available Tue 06/30/20 - Wed 06/30/21 0.50 Prescribed credits